SomaLogic, Inc.

NASDAQ:SLGC

2.1 (USD) • At close January 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2022202120202019
Operating Activities:
Net Income -109.157-87.547-53.015-57.002
Depreciation & Amortization 4.5712.5692.8233.157
Deferred Income Tax -0.80611.60513.083-8.199
Stock Based Compensation 43.60928.41515.17213.066
Change In Working Capital 28.0095.682-8.667-4.867
Accounts Receivables -9.3660.383-13.3060.084
Inventory -3.732-2.9570.483-4.951
Accounts Payables 2.346.464.0250
Other Working Capital 38.7671.7960.1310
Other Non Cash Items -66.8952.3042.2663.309
Operating Cash Flow -100.669-36.972-28.338-50.536
Investing Activities:
Investments In Property Plant And Equipment -5.215-6.729-1.157-0.68
Acquisitions Net -13.256000
Purchases Of Investments -186.687-279.918-45.7020
Sales Maturities Of Investments 287.7101.20637.2730
Other Investing Activites 00.010.05131.345
Investing Cash Flow 82.542-185.431-9.53530.665
Financing Activities:
Debt Repayment 0-36.51200
Common Stock Issued 5.185357.19800
Common Stock Repurchased 0000
Dividends Paid 0000
Other Financing Activities 0176.805188.7660.144
Financing Cash Flow 5.185497.491188.7660.144
Other Information:
Effect Of Forex Changes On Cash -0.043-0.014-0.009-0.017
Net Change In Cash -12.985275.074150.884-19.744
Cash At End Of Period 427.283440.268165.19414.31